Website:
ANT Neuro
Catalog excerpts
Treatment of Psychiatric Disorders The visor2 system is not available for sale in all countries, please refer to the associated visor2 specification documents or contact you local representative for details. https://www.ant-neuro.com/contact-us
Open the catalog to page 1
Treatment of Psychiatric Disorders One-third of adults with Major Depressive Disorder (MDD) have experienced persistent symptoms which do not respond to pharmacological treatment. Navigated repeated TMS (rTMS) has been approved by the U.S. FDA and several regulatory agencies around the world as a non-invasive treatment for Major Depressive Disorder. rTMS has been proven beneficial for treatment-resistant MDD patients who had not previously responded to any antidepressant medication. More recently, long-term gains have been observed in MDD patients receiving rTMS treatment followed by...
Open the catalog to page 2All ANT Neuro catalogs and technical brochures
-
eego™24 brochure3 Pages
-
waveguard™net brochure3 Pages
-
waveguard™original brochure7 Pages
-
waveguard™touch brochure3 Pages
-
waveguard™connect brochure2 Pages
-
asa™ brochure3 Pages
-
xensor™ brochure3 Pages
-
smartmove™ datasheet2 Pages
-
smartmove™ brochure3 Pages
-
eego™rt brochure3 Pages
-
eego™8 brochure3 Pages
-
nëo™ brochure3 Pages
-
visor2™ brochure3 Pages
-
eego™sports brochure3 Pages
-
eego™mylab brochure3 Pages
-
cognitrace™ brochure2 Pages
